Posted 3/23/2024, 12:14:00 PM
FDA Approves New Pancreatic Cancer Drug Regimen, First in Nearly 10 Years
- The FDA approved a new drug regimen for metastatic pancreatic cancer, the first in nearly 10 years
- The new regimen showed improved survival rates compared to standard treatment in a large clinical trial
- It combines the new drug Onivyde with several existing chemotherapy medications
- Onivyde works by interfering with cancer cell DNA repair and replication
- The regimen has significant side effects like diarrhea and dehydration that need to be managed
